The Limited Times

Now you can see non-English news...

Corona: vaccine breakthrough in Germany - but will it be delivered abroad first? Spahn becomes clear

2020-11-10T13:47:37.892Z


The world is eagerly waiting for corona vaccines. Experts are now clarifying who in Germany should be vaccinated against the coronavirus first - and how many vaccinations are required. The news ticker.


The world is eagerly waiting for corona vaccines.

Experts are now clarifying who in Germany should be vaccinated against the coronavirus first - and how many vaccinations are required.

The news ticker.

  • Scientists

    around the

    world are researching the

    coronavirus *

    and trying

    to develop

    a

    vaccine *

    .

  • But who will be vaccinated first?

    According to

    Federal Chancellor Angela Merkel (CDU)

    , experts - for example from the

    Standing Vaccination Commission

    - take a position

    .

    (see update from November 9th, 11.30 a.m.).

  • The German company

    Biontech

    reports an effective

    corona vaccine

    (

    see update from November 9th, 12.55 p.m.

    ).

  • Here you will find the Corona news from Germany and a map of the current infection situation.

Update from November 10th, 10:32 am

: At a joint press conference with Philipp Justus,

Vice President of Google

in Central Europe, Federal Health

Minister

Jens Spahn (CDU)

once again emphasized in his ministry in Berlin that he would be “in the next few days” contract with

BioNTech

counting

(see previous update)

.

At the moment, "questions of liability and procedural law as well as questions of price need to be clarified," said Spahn.

The EU Commission was mandated with this task: “We could have concluded the contracts nationally - the only question is whether that would have been our solidarity view in the EU, that economically not so strong EU member states would have to wait months for the vaccination doses received later than others. " 

When asked, Spahn said that the federal government was assuming

"up to 100 million vaccine

doses

" of

the

Biontech Pfizer agent

to be secured for Germany.

In Berlin, Justus and Spahn presented a

cooperation between

the Federal

Ministry

of Health and the search engine on the website

gesundheit.bund.de

.

The portal has been online for a good two months and presents

“evidence-based”

and “clear” information on currently

160 diseases

, according to Spahn.

Google uses an

open interface to

place the data

prominently in its search results.

Biontech / Pfizer: Spahn wants to press for a quick delivery contract for corona vaccine from the EU

Update from November 10th, 6.59 am

: Federal

Minister of

Health

Jens Spahn (CDU *)

wants the

EU

to

sign

a delivery contract

with the German research company

Biontech

and its US partner

Pfizer

as soon as possible ("in the next few days")

of their promising

corona vaccine candidate

(see previous update)

.

So far there is only one preliminary contract with the two companies, said Spahn on Monday evening on ZDF.

"As the German health

minister, I

would

find it difficult to explain if a vaccine produced in Germany were vaccinated more quickly in other regions of the world

than in Germany itself," stressed Spahn.

The CDU politician said that the successes announced by Biontech and Pfizer were "in any case very encouraging" and made one confident.

An

effectiveness of 90 percent

is very high.

In

comparison,

a

flu vaccine is

only 50 or 60 percent effective, explained the minister.

The interview by @CHSievers with the Minister of Health @jensspahn on #Impfstrategy and #Vaccine is already in the media library: "There can be setbacks in approval" https://t.co/nPnq36S5vN

- ZDF heute journal (@heutejournal) November 9, 2020

Corona vaccine from Biontech / Pfizer: Spahn does not want to "lower the standards"

Spahn also emphasized that the requirements for the vaccine would "not be changed or scaled down".

The material has to be

"well researched"

, whatever happens.

Biontech and Pfizer vaccine candidates are subject to "the same high standards" as everyone else, "said the minister, adding that this is" very important "in order to gain people's trust in this potential vaccine.

From EU circles it was said on Monday that the European Union wanted to stick to its

previous schedule

for the approval of a corona vaccine,

despite the positive announcement from Biontech and Pfizer

.

The

European Medicines Agency Ema has to

carry out further tests, so approval in Europe is not

realistic

until

"early next year" at the

earliest

.

+

Federal Minister of Health Jens Spahn (CDU) wants to put pressure on the delivery of a corona vaccine.

© Michael Kappeler / dpa

Corona: "90 percent effective" - ​​vaccine breakthrough in Germany?

Spahn with an emotional statement

Update, 6.46 p.m

.: Two messages caused euphoria on the international stock markets on Monday:

Joe Biden's

victory

in the US presidential election and especially the announcement by the Mainz-based pharmaceutical company

Biontech

and its US partner

Pfizer

over one to more than 90 percent effective corona vaccine caused massive increases in the stock market barometers internationally.

The

German share index

(

Dax

) climbed by almost five percent.

The shares of

Biontech

and

Pfizer

recorded significant price jumps

.

The

Dax

closed in

Frankfurt am Main

with a clear increase of 4.94 percent at the closing price on Friday.

The leading German index landed at 13,095.97 points.

The price gains in France were even more massive.

The leading French index CAC 40 climbed 7.57 percent.

The FTSE 100 also rose significantly on the London Stock Exchange.

The stock market barometer in Athens even recorded an increase of 11.46 percent.

Corona vaccine for Germany: Lauterbach - "You can call it a breakthrough without exaggeration"

Update, 3 p.m.: SPD health expert Karl Lauterbach

, often in focus in the corona crisis, commented on the reports of an effective

coronavirus vaccine from Germany

.

“Intermediate results can be called a breakthrough without exaggeration.

I never doubted that we would be vaccinated.

Now you have to hope that even very difficult courses will be prevented.

The evaluated cases do not show that, ”Lauterbach wrote on

Twitter

about the announcements by the German pharmaceutical company

Biontech

.

Intermediate results can be called a breakthrough without exaggeration.

I never doubted that we would be vaccinated.

Now you have to hope that even very difficult courses will be prevented.

The evaluated cases do not show that https://t.co/ouoZxTLoZ6

- Karl Lauterbach (@Karl_Lauterbach) November 9, 2020

Corona vaccine from Germany: Health Minister Jens Spahn with an emotional statement

Update, 1.30 p.m.: Federal Minister of Health Jens Spahn (CDU) spoke about the

corona vaccine

in Berlin

.

"As of today, there will be a

vaccine

against a new virus faster

than ever before in human history,

" says Spahn in an emotional statement and clarifies: "There will be a voluntary

vaccination

, that will be a vaccination offer.

In the first few weeks and months there will not be enough vaccine for everyone who wants to be vaccinated.

That is why we have to prioritize. ”



“ Vaccination centers ”are needed, the department head continues.

There has already been an agreement with the federal states to “set up these

vaccination centers

.

"Nobody can answer the question of what amount is available and when," he said in response to a reporter question about when the majority of the population had been vaccinated so that they could feel safe.

Spahn

is on the German company

BioNTech

addressed, which had announced this Monday that his agent to 90 percent effective against the

coronavirus

was.

“The teams are in contact with all developers.

As of today, the data on effectiveness are very encouraging.

That there is a

vaccine

that works,

that's what it

looks like, "explains Spahn, and says with regard to

Biontech

:" As the German Minister of Health, I am of course very pleased that a German company first, and a German research team first, the effectiveness can prove. "

Vaccine against the coronavirus: Biontech wants approval for active ingredient against Covid-19

Update, 12.55 p.m.:

A pharmaceutical company is now on the offensive - and announces a sensational interim result for its

corona vaccine

.

Specifically: The Mainz-based pharmaceutical company

Biontech

has announced that tests have shown that its vaccination

offers

more than 90 percent protection against the

insidious lung disease Covid-19

.

That writes the news portal

n-tv.de

.

According to the report,

Biontech

and the pharmaceutical company Pfizer

want to

apply for

approval from the US FDA next week.

There are apparently no

official confirmations from authorities about the effectiveness of the

coronavirus vaccine

.

Corona vaccine for Germany: "70 percent of people have to get vaccinated"

Update, 11.30 a.m .: Prof. Dr.

Gerald Haug

, President of the German Academy of Sciences Leopoldina, is now speaking in

Berlin.


"I am full of hope that we will take huge steps to defeat the pandemic in 2021," he says - Haug also announces that we will "have effective vaccines available very soon".

He cites the number of

vaccinations

required

in Germany

:

"70 percent of people have to take part and get vaccinated in

order to be highly effective," explains the expert.



There is “appropriate optimism to leave the pandemic behind us next year”, he continues and wants “to look to summer 2021 with a lot of optimism.

If everyone pulls together, we will take decisive steps by summer to leave the pandemic behind us ”.

Corona vaccination in Germany: "Vaccines will be available very soon"

Update, 11.20 a.m.:

Now is

Prof. Dr.

It is Alena Buyx's turn, the chairwoman of the German Ethics Council.

“Vaccines will be available very soon

.

Who will get it first?

In the beginning they will be scarce, ”says Buyx and explains the ethical framework for vaccinations for the German population.

The focus is on the term “solidarity”.

It's about the following:

Vaccine against the coronavirus: Experts explain the sequence for vaccinations against Sars-CoV-2

  • Prevention of severe (corona) cases

  • Protecting people at high risk

  • Maintaining the state functionality

The people who have the highest risk of death and severe disease need to be protected, she explains, “people with old age or a bad state of health.

She cites nursing homes as an example.

And further: “Those who stand by the sick, that is, those who work in the health service.

Employees of inpatient or outpatient facilities "

When

prioritizing the corona vaccination

, "people who are important for the community, i.e. employees of the health authorities, fire brigade, police, teachers and educators" are right at the front.

Covid-19 risk groups

and groups important for the community should be vaccinated at the same time.

To put it simply: a young nurse can be vaccinated more easily and quickly than a nursing home resident.

Chancellor Angela #Merkel wants to use an urgently awaited vaccine against #Corona to protect the health system itself.

# Doctors, # nurses and # risk groups should be vaccinated first.

#Corona vaccine https://t.co/GvOj7GkGnd pic.twitter.com/eg6kdrM2AY

- APOTHEKE ADHOC (@ApothekeAdhoc) November 8, 2020

Corona vaccine for Germany: "We are all eagerly waiting for the vaccine"

Update from November 9, 11.10 a.m.:

The federal press conference on the

corona vaccine in Germany is

running in Berlin

.

Prof. Dr.

Thomas Mehrtens, Chairman of the Standing Vaccination Commission

, begins with his statement.

“We are all eagerly waiting for the vaccine.

We all have great hope in the vaccine - and rightly so.

We can only get a grip on both old and new infectious diseases if we have an effective vaccine, "said the virologist and says:" It will be a step forward if we have a vaccine available soon. "

Mostly explains the difficulties and challenges.

“We are still waiting for the results of the phase III study.

We have never looked at a vaccine that has never been approved.

For reasons that are known to everyone, this time we had to start before the vaccine was approved, "Mehrtens continues:" It will not be possible to provide a vaccine to all of our population who are willing to vaccinate from the start.

The greatest benefit for the entire population must come out of it. "

Corona vaccine for Germany: Experts comment on the federal press conference in Berlin

Update from November 9th, 10.15 a.m

.: This Monday there is news about the

corona vaccine in Germany

.

Specifically: A joint position paper will be presented at the federal press

conference

entitled: “How should access to a

Covid-19 vaccine be

regulated?” We will of course keep you up to date.

Coronavirus vaccine for Germany: New record levels of corona infections

Update from November 8, 2020:

The

coronavirus

continues to spread, on

Saturday

the

Robert Koch Institute

reported

an absolute record in Germany

with over 23,000

new infections

within 24 hours.

On

Sunday

, Angela Merkel said again, in a video for the "Open House", the Chancellor declared that the urgently awaited

vaccine will

probably first be used to protect the health system.

"The question of who will be vaccinated first is discussed with the Standing

Vaccination Commission

, the Leopoldina Science Academy and the Ethics Committee," said

Merkel

in the video in which the

Chancellor

answered public questions.

“But I think I can reveal so much that I say that right at the front are, of course, nurses, doctors and also people who belong to a

risk group

.

But then there are quite a few in our country, ”said Merkel.

It

is not yet clear

when exactly a

vaccine will be

available.

But the

federal government

hopes that the first vaccines will be approved very soon.

"Then of course there will not be enough vaccine available," said the

Chancellor

and emphasized: "Nobody will be forced to be vaccinated, it is a voluntary decision."



Preparations for a

vaccination campaign were

underway.

The

federal states

planned their own vaccination centers.

We still have to see how much

vaccine

will be available and how long this vaccine will immunize.

The central task is to make the population as a whole immune to the virus.

If 60 to 70 percent of the population are immune - due to a vaccination or an illness they have survived - the virus is "more or less defeated," said Merkel.

"Then we can lift all restrictions as well," she said.

Corona vaccine: German head of research gives harsh forecast - "Pandemic will not be defeated in 2021"

First report from October 31, 2020:

Munich / Frankfurt - Since the

coronavirus spread

around the world, scientists * have been researching the development of an effective

vaccine

at full

speed

.

The pharmaceutical company

Sanofi-Aventis is also

working on it.

In an interview with

WirtschaftsKurier

, the head of

research and development for Germany explained

which vaccines could be available, how safe they are and whether he would have himself tested.

He also described that one thing in the corona pandemic was different than usual.

Corona vaccine: three types are being worked on

In principle, three types of vaccine would be tested, as

Jochen Maas

explains:

Vaccine type

description

Experience

Live vaccines

Attenuated viruses are used as carriers of the immunizing antigen.

A high level of security through a lot of experience

Dead vaccines

This substance only contains protein, no viruses.

There is a residual risk.

mRNA vaccines

In the process, small pieces of genetic information are administered, which trigger the production of the antigen in the human cells.

No long-term data yet

Even if there are different experiences, Maas makes no difference for himself personally: “I would get vaccinated with all three types.

Because if they are approved, they are also safe.

"With regard to the plans for a dead vaccine, Maas said:" If we receive approval, Sanofi will probably bring such a vaccine onto the market in the summer of next year. "An insulin filling plant in Frankfurt is already being converted for this purpose.

“We will manufacture 200 million cans per year there,” says the pharmaceutical entrepreneur.

A lot of money has to be invested in the development of a vaccine without any certainty whether the substance will even be approved by the authorities.

The

risk

that enter the company here Maas called

"exorbitantly high"

.

"So far, Sanofi has invested a three-digit million sum in research, development and testing of a vaccine without knowing whether it will work," says Maas.

Corona vaccines should remain affordable: "No company will be able to make a profit"

Still, it would regulate that prices would not go so high and that a company could make extreme profits from the vaccines.

“Governments everywhere will ensure that the vaccine

remains

affordable

and no company will be able to make a profit here.

I expect that the price for one dose will be affordable for everyone, including the poorer countries, ”Maas explained.

Even if there is great economic potential in vaccine development, the race is more collegial than hostile.

“The enemy is not the competitor, but the virus.

Everyone sees it that way.

The science and business community works together excellently across borders and continents.

The authorities and politics are also pulling along.

Everyone knows we're in the same boat.

Everyone knows that no one can produce eight billion vaccine doses alone, ”said Maas, describing the“ unique ”situation in an interview with

WirtschaftsKurier

.

Corona: far-reaching immunization not yet foreseeable - "a gigantic logistical undertaking"

While the prospects for a

vaccine

are good right now, that doesn't mean the pandemic will be over next year.

“If the vaccine is there, it is very good, but it will not improve our situation immediately.

It then has to be mass produced, bottled and distributed.

We need four to eight billion doses of vaccine worldwide, depending on whether a simple vaccination is sufficient or whether it has to be repeated.

It's a gigantic logistical undertaking,

”says Maas, describing the challenge.

Nonetheless,

widespread vaccination of

the population appears to be the only long-term effective means of ending the pandemic.

The worldwide cooperation gives hope for a cooperative, international strategy.

(lb) * Merkur.de is part of the Ippen-Digital network

List of rubric lists: © Michael Kappeler / dpa

Source: merkur

All news articles on 2020-11-10

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.